News for Indivior PLC (INDV.L)

Decision by the fintech to move primary listing to New York is latest blow to LSE

Firm behind opioid addiction treatment drugs quits London Stock Exchange after moving primary to US last year

The U.S. stock market opened lower on Monday, June 2, 2025, as renewed tensions between the United States and China weighed on investor sentiment. As of early

PR NewswireSLOUGH, England and RICHMOND, Va., June 2, 2025 SLOUGH, England and RICHMOND, Va., June 2, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV)

PR NewswireRICHMOND, Va., May 27, 2025 Seasoned commercial executive with more than 30 years of pharmaceutical experienceRICHMOND, Va., May 27, 2025 /PRNew

Indivior PLC (INDV) appoints Patrick Barry as Chief Commercial Officer, effective June 2, 2025. Barry brings over 30 years of experience in the pharmace

PR NewswireRICHMOND, Va., May 13, 2025 RICHMOND, Va., May 13, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate

\nIndivior PLC (INDV) showcases a robust portfolio with products like Sublocade and Suboxone, driving its competitive edge in addiction treatment.Despite a stron

Study shows SUBLOCADE® poses no increased risk during pregnancy. Opioid use during pregnancy spiked 131% from 2010-2017. Research informs treatment

Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings. Find out why INDV stock is a hold.

Shares of Indivior PLC (INDV) surged 3.90% in mid-day trading on Apr 25. The stock reached an intraday high of $11.22, before settling at $11.18, up from it

Apr 24, 2025 / 12:00PM GMTOperator Good day and thank you for standing by. Welcome to the Indivior PLC Q1, 2025 Financial results conference call. (Operator Ins

Indivior PLC (NASDAQ:INDV) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ETCompany ParticipantsJason Thompson - Head, IRMark Crossley - CEORyan...

Revenue: $266 million, surpassing the estimated $240.13 million.Earnings Per Share (EPS): $0.38, exceeding the estimated EPS of $0.22.Net Income: $47 million,

Indivior (INDV) delivered earnings and revenue surprises of 86.36% and 11.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Indivior (INDV) has announced its financial results for the first quarter, revealing revenues of $266 million. This figure exceeds analysts' expectations, which

The company has reaffirmed its financial projections for fiscal year 2025, maintaining its outlook on gross margins and operating income. The anticipated gross

PR NewswireSLOUGH, United Kingdom and RICHMOND, Va., April 24, 2025 SLOUGH, United Kingdom and RICHMOND, Va., April 24, 2025 /PRNewswire/ -- Indivior PLC (

Indivior (INDV) releases Q1 2025 financial results for the period ending March 31, 2025. The company will host a live webcast at 13:00 BST (8:00 am ET)